Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Croatia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Croatia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20063
20071
20081
20091
20102
20113
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
Corcept Therapeutics2
Eli Lilly and Company2
AstraZeneca1
Neurocrine Biosciences1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Pfizer1
Shire1
Sumitomo Pharma America, Inc.1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder15
Depressive Disorder3
Psychotic Disorders2
Dysthymic Disorder1
Mood Disorders1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.